Hill October 24, 2021
Raegan McDonald-Mosley

As a practicing obstetrician-gynecologist and advocate for improving access to reproductive and sexual health and resources, I have witnessed firsthand how our health care system too often fails those with the greatest barriers to accessing health care and services.

The Biden administration has a unique opportunity to nominate a Food and Drug Administration (FDA) commissioner who will boldly tackle systemic bias and barriers in health care, champion evidence-based science and advance health equity. The next FDA commissioner will play a pivotal role in determining the direction of our nation’s health care. The administration must consider the needs of people and communities and their ability to access health care. The pandemic has demonstrated how important it is to have leaders in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Equity/SDOH, FDA, Govt Agencies, Healthcare System, Patient / Consumer, Provider
FDA approves Lumicell’s breast cancer imaging tool
Boehringer Ingelheim Strikes Regenerative Med R&D Deal Spanning MASH & More Liver Diseases
Opinion: An FDA pathway can accelerate innovation for Duchenne muscular dystrophy
What principles should guide artificial intelligence innovation in healthcare?
Roche Drug Scores Label Expansion for Earlier Use in Lung Cancer

Share This Article